Kringle Pharma, Inc.

2026/10/09 19:27 Updated
Market Cap: $32.9M (¥5.2B)
Stock Price: $4.08 (¥645)
Exchange Rate: 1 USD = ¥158.23

Investigation Completion of the Protocol in the Phase III Add-On Trial of Hepatocyte Growth Factor for Acute Spinal Cord Injury

Importance:
Page Updated: September 21, 2026
IR Disclosure Date: July 3, 2026
Other

Kringle Pharma, Inc.

Company overview · Stock price · Financial data · All IR

View company page →